CBS 2019
CBSMD教育中心
English

充血性心力衰竭

科研文章

荐读文献

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction Effects of Liraglutide on Cardiovascular Outcomes in Patients With Diabetes With or Without Heart Failure From ACE Inhibitors/ARBs to ARNIs in Coronary Artery Disease and Heart Failure (Part 2/5) A Randomized Controlled Trial to Evaluate the Safety and Efficacy of Cardiac Contractility Modulation Lifestyle Modifications for Preventing and Treating Heart Failure SGLT-2 Inhibitors and Cardiovascular Risk: An Analysis of CVD-REAL Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to Age: Insights From DAPA-HF Economic and Quality-of-Life Outcomes of Natriuretic Peptide–Guided Therapy for Heart Failure H2FPEF Score for Predicting Future Heart Failure in Stable Outpatients With Cardiovascular Risk Factors Nocturnal thoracic volume overload and post-discharge outcomes in patients hospitalized for acute heart failure

Guideline2018 Oct 24;46(10):760-789.

JOURNAL:中华心血管病杂志 Article Link

中国心力衰竭诊断和治疗指南2018

中华医学会心血管病学分会心力衰竭学组, 中国医师协会心力衰竭专业委员会中华心血管病杂志编辑委员会 Keywords: heart failure; guideline; China

LINK


自"中国心力衰竭诊断和治疗指南2014"发布以来,心力衰竭(心衰)的诊疗、预防及综合管理等相关领域有不少新进展,为此,中华医学会心血管病学分会心力衰竭学组、中国医师协会心力衰竭专业委员会、中华心血管病杂志编辑委员会组织专家组,根据国内外最新临床研究成果,参考2017年美国心脏病学会(ACC)/美国心脏协会(AHA)以及2016年欧洲心脏病学会(ESC)等发布的相关指南,结合我国国情及临床实践,对"中国心力衰竭诊断和治疗指南2014"进行更新。